Orthofix Medical - OFIX Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $18.00
  • Forecasted Upside: 13.85%
  • Number of Analysts: 5
  • Breakdown:
  • 0 Sell Ratings
  • 3 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$15.81
▲ +0.04 (0.25%)

This chart shows the closing price for OFIX by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Orthofix Medical Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for OFIX and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for OFIX

Analyst Price Target is $18.00
▲ +13.85% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for Orthofix Medical in the last 3 months. The average price target is $18.00, with a high forecast of $20.00 and a low forecast of $16.00. The average price target represents a 13.85% upside from the last price of $15.81.

This chart shows the closing price for OFIX for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 5 contributing investment analysts is to hold stock in Orthofix Medical. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 2 buy ratings
  • 3 hold ratings
  • 0 sell ratings
1/23/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 3 hold ratings
  • 0 sell ratings
4/23/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 3 hold ratings
  • 0 sell ratings
7/22/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 3 hold ratings
  • 0 sell ratings
10/20/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 3 hold ratings
  • 0 sell ratings
1/18/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 3 hold ratings
  • 0 sell ratings
4/17/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 3 hold ratings
  • 0 sell ratings
6/16/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 3 hold ratings
  • 0 sell ratings
7/16/2024

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 3 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/8/2024Roth CapitalUpgradeNeutral ➝ BuyLow
5/8/2024Roth MkmUpgradeNeutral ➝ Buy$15.00 ➝ $20.00Low
4/22/2024JMP SecuritiesReiterated RatingMarket PerformLow
3/7/2024Roth MkmBoost TargetNeutral ➝ Neutral$12.00 ➝ $15.00Low
10/20/2023Roth MkmInitiated CoverageNeutral$12.00Low
9/12/2023BTIG ResearchDowngradeBuy ➝ NeutralLow
9/12/2023Stifel NicolausDowngradeBuy ➝ Hold$30.00 ➝ $16.00Low
3/4/2022Stifel NicolausUpgradeHold ➝ Buy$41.00 ➝ $45.00High
10/20/2020Stifel NicolausInitiated CoverageHold$39.00Medium
2/25/2020SidotiLower TargetBuy$70.00 ➝ $56.00High
2/25/2020Cantor FitzgeraldLower TargetNeutral$48.00 ➝ $42.00High
10/29/2019Cantor FitzgeraldDowngradeOverweight ➝ Neutral$71.00 ➝ $48.00Low
(Data available from 7/16/2019 forward)

News Sentiment Rating

0.42 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/19/2023
  • 5 very positive mentions
  • 5 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
1/18/2024
  • 2 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/17/2024
  • 8 very positive mentions
  • 7 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
3/18/2024
  • 2 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/17/2024
  • 8 very positive mentions
  • 14 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
5/17/2024
  • 4 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/16/2024
  • 1 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/16/2024

Current Sentiment

  • 1 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.
Orthofix Medical logo
Orthofix Medical Inc. operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations. The Global Orthopedics segment offers products and solutions that allow physicians to treat various orthopedic conditions related to limb reconstruction and deformity correction unrelated to the spine. This segment designs, develops, and markets external and internal fixation orthopedic products that are coupled with enabling digital technologies to serve the complete patient treatment pathway. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, and healthcare providers. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.
Read More

Today's Range

Now: $15.81
Low: $15.68
High: $16.15

50 Day Range

MA: $13.96
Low: $12.38
High: $15.81

52 Week Range

Now: $15.81
Low: $9.57
High: $21.60

Volume

378,164 shs

Average Volume

364,900 shs

Market Capitalization

$593.33 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.05

Frequently Asked Questions

What sell-side analysts currently cover shares of Orthofix Medical?

The following equities research analysts have issued research reports on Orthofix Medical in the last twelve months: BTIG Research, JMP Securities, Roth Capital, Roth Mkm, Stifel Nicolaus, and StockNews.com.
View the latest analyst ratings for OFIX.

What is the current price target for Orthofix Medical?

2 Wall Street analysts have set twelve-month price targets for Orthofix Medical in the last year. Their average twelve-month price target is $18.00, suggesting a possible upside of 13.9%. Roth Mkm has the highest price target set, predicting OFIX will reach $20.00 in the next twelve months. Stifel Nicolaus has the lowest price target set, forecasting a price of $16.00 for Orthofix Medical in the next year.
View the latest price targets for OFIX.

What is the current consensus analyst rating for Orthofix Medical?

Orthofix Medical currently has 3 hold ratings and 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in OFIX, but not buy more shares or sell existing shares.
View the latest ratings for OFIX.

What other companies compete with Orthofix Medical?

Other companies that are similar to Orthofix Medical include Anika Therapeutics, Intersect ENT, Vapotherm, Alphatec and AtriCure. Learn More about companies similar to Orthofix Medical.

How do I contact Orthofix Medical's investor relations team?

Orthofix Medical's physical mailing address is 3451 Plano Parkway, Lewisville TX, 75056. The medical device company's listed phone number is (214) 937-2000 and its investor relations email address is [email protected]. The official website for Orthofix Medical is www.orthofix.com. Learn More about contacing Orthofix Medical investor relations.